Statement of Organization, Functions, and Delegations of Authority, 16310-16311 [06-3123]
Download as PDF
<![CDATA[
16310
Federal Register / Vol. 71, No. 62 / Friday, March 31, 2006 / Notices
being of older Americans. Deliverables
required by the AoA of all Title IV
grantees are the semi-annual and final
reports, as provided for in Department
of Health and Human Services
regulations, 45 CFR Part 74, Section
74.51. The proposed guidelines may be
found on the Administration on Aging
Web site at https://www.aoa.gov/
doingbus/grantrep/grantrep.asp.
AoA estimates the burden of this
collection of information as follows:
Semi-annual submission with the final
report taking the place of the semiannual report at the end of the final year
of the grant. Respondents: States, public
agencies, private nonprofit agencies,
institutions of higher education, and
organizations including tribal
organizations. Estimated Number of
Responses: 600. Total Estimated Burden
Hours: 12,000.
Dated: March 28, 2006.
Josefina G. Carbonell,
Assistant Secretary for Aging.
[FR Doc. E6–4696 Filed 3–30–06; 8:45 am]
Announcements PA–04–038, PA–04–021,
PA–04–030, and PAR–04–105.
For Further Information Contact:
Charles N. Rafferty, PhD, Designated
Federal Official, National Institute for
Occupational Safety and Health, CDC,
1600 Clifton Road, NE., Mailstop E–74,
Atlanta, GA 30333; Telephone Number
404.498.2582. The Director,
Management Analysis and Services
Office, has been delegated the authority
to sign Federal Register notices
pertaining to announcements of
meetings and other committee
management activities, for both CDC
and the Agency for Toxic Substances
and Disease Registry.
Dated: March 27, 2006.
Alvin Hall,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E6–4708 Filed 3–30–06; 8:45 am]
BILLING CODE 4163–18–P
BILLING CODE 4154–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention
Statement of Organization, Functions,
and Delegations of Authority
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panels (SEP): Member
Conflict: Safety and Occupational
Health, Program Announcements PA–
04–038, PA–04–021, PA–04–030, and
PAR–04–105
Part C (Centers for Disease Control
and Prevention) of the Statement of
Organization, Functions, and
Delegations of Authority of the
Department of Health and Human
Services (45 FR 67772–76, dated
October 14, 1980, and corrected at 45 FR
69296, October 20, 1980, as amended
most recently at 71 FR 6777, dated
February 9, 2006) is amended to reflect
the reorganization of the Division of
Birth Defects and Developmental
Disabilities, within the National Center
on Birth Defects and Developmental
Disabilities.
Section C–B, Organization and
Functions, is hereby amended as
follows:
After the mission statement for the
Division of Birth Defects and
Developmental Disabilities (CUBB),
insert the following:
Office of the Director (CUBB1). (1)
Manages, directs, and coordinates the
research agenda and activities of the
division; (2) provides leadership and
guidance on strategic planning, policy,
program and project priority planning
and setting, program management, and
operations; (3) establishes division
goals, objectives, and priorities; (4)
monitors progress in implementation of
projects and achievement of objectives;
(5) plans, allocates, and monitors
dsatterwhite on PROD1PC76 with NOTICES
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting:
Name: Disease, Disability, and Injury
Prevention and Control Special Emphasis
Panel (SEP): Member Conflict: Safety and
Occupational Health, Program
Announcements PA–04–038, PA–04–021,
PA–04–030, and PAR–04–105.
Time and Date: 2 p.m.–5 p.m., April 20,
2006 (Closed).
Place: National Institute for Occupational
Safety and Health, CDC, 24 Executive Park
Drive NE, MS E–74, Room 1429, Atlanta, GA
30329; Telephone Number 404.498.2582.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters To Be Discussed: The meeting will
include the review, discussion, and
evaluation of applications received in
response to: Member Conflict: Safety and
Occupational Health, Program
VerDate Aug<31>2005
18:41 Mar 30, 2006
Jkt 208001
PO 00000
Frm 00031
Fmt 4703
Sfmt 4703
resources; (6) provides management,
administrative, and support services,
and coordinates with appropriate
NCBDDD offices on program and
administrative matters; (7) provides
liaison with other CDC organizations,
other governmental agencies,
international organizations, and other
outside groups; (8) provides support for
internal scientific advisory groups; (9)
provides scientific leadership and
guidance to the division to assure
highest scientific quality and
professional standards; and (10)
provides coordinative support for CDC’s
efforts to reduce adverse consequences
from birth defects, developmental
disabilities, and pediatric genetic
conditions.
Birth Defects Branch (CUBBB). (1)
Designs and conducts epidemiologic
and genetic research to identify causes
and risk factors of birth defects; (2)
conducts evaluates interventions to
improve infant and child health by
preventing or reducing the adverse
consequences of birth defects; (3)
designs and conducts surveillance of
selected birth defects to identify rates,
trends, and patterns of occurrence, and
to evaluate the effectiveness of
prevention programs; (4) disseminates
findings of studies to the scientific and
public health communities, and to the
general public; (5) provides technical
assistance to state and local agencies on
surveillance of birth defects,
epidemiologic research, prevention
program design and evaluation, and
prevention effectiveness research; (6)
funds and coordinates grant and
cooperative agreement programs and
other extramural activities to improve
the knowledge base for the prevention
of birth defects through surveillance,
epidemiologic research, and applies
research of preventive interventions; (7)
coordinates activities with other CDC
functional units, HHS, other federal
agencies,and appropriate private
organizations regarding research and
prevention programs for birth defects;
(8) works with international
organizations in developing strategies
for the prevention of birth defects; and
(9) disseminates findings of research
through direct contact with health
authorities, publication and distribution
of special reports, publication in
scientific and technical journals,
conference presentations, and other
appropriate means.
Prevention Research Branch (CUBBC).
(1) Modifies the impact of prenatal
exposures leading to adverse physical
and developmental impairments in
infants, children, and adults including
integrating successful prevention
programs into social and medical
E:\FR\FM\31MRN1.SGM
31MRN1
dsatterwhite on PROD1PC76 with NOTICES
Federal Register / Vol. 71, No. 62 / Friday, March 31, 2006 / Notices
environments, and evaluating
innovative, effective, and strategic
health promotion programs; (2)
develops, implements, evaluates, and
disseminates education and
communication interventions that lead
to the prevention of birth defects and
developmental disabilities; (3) designs
and conducts surveillance of
preventable birth defects and
developmental disabilities to identify
rates, trends, and patterns of occurrence,
and to evaluate the effectiveness of
prevention programs; (4) disseminates
findings of epidemiologic studies to the
scientific and public health
communities, and to the general public;
(5) conducts prevention effectiveness
research to evaluate interventions
strategies for the prevention of birth
defects and developmental disabilities;
(6) identifies and monitors major
preconception, prenatal and perinatal
risks, and protective factors for fetal
alcohol spectrum disorders (FASD) and
other prenatal alcohol-attributable
conditions; (7) provides technical
assistance to state and local agencies on
surveillance, epidemiologic research,
prevention program design and
evaluation, and prevention effectiveness
research; (8) funds and coordinates
grant and cooperative agreement
programs and other extramural activities
to improve the knowledge base for the
prevention of birth defects and
developmental disabilities through
surveillance, epidemiologic research,
and applies research of preventive
interventions; (9) coordinates activities
with other CDC functional units, HHS,
other federal agencies and appropriate
private organizations regarding research
and prevention programs for birth
defects and developmental disabilities;
(10) works with international
organizations in developing strategies
for the prevention of birth defects and
developmental disabilities; and (11)
disseminates finding of research
through direct contact with health
authorities, publication and distribution
of special reports, publication in
scientific and technical journals,
conference presentations, and other
appropriate means.
Developmental Disabilities Branch
(CUBBD). (1) Designs and conducts
surveillance of developmental
disabilities to identify rates, trends, and
patterns of occurrence, and to evaluate
the effectiveness of prevention
programs; (2) conducts epidemiologic
studies of developmental disabilities to
identify causes and risk factors for these
conditions; (3) disseminates findings of
epidemiologic studies to the scientific
and public health communities and to
VerDate Aug<31>2005
16:35 Mar 30, 2006
Jkt 208001
the general public; (4) conducts
prevention effectiveness research to
evaluate interventions strategies for the
prevention of developmental
disabilities; (5) conducts epidemiologic
studies to identify and describe specific
conditions and long-term outcomes of
developmental disabilities; (6) provides
technical assistance to state and local
agencies on surveillance of
developmental disabilities,
epidemiologic research, prevention
program design and evaluation, and
prevention effectiveness research; (7)
funds and coordinates grant and
cooperative agreement programs and
other extramural activities to improve
the knowledge base for the prevention
of developmental disabilities through
surveillance, epidemiologic research,
and applies research of preventive
interventions; (8) coordinates activities
with other CDC functional units, HHS,
other Federal agencies and appropriate
private organizations regarding research
and prevention programs for
developmental disabilities; (9)
collaborates with international
organizations in developing strategies
for the prevention of developmental
disabilities; (10) disseminates findings
of research through direct contact with
health authorities, publication and
distribution of special reports,
publication in scientific and technical
journals, conference presentations, and
other appropriate means; and (11)
provides training in the epidemiology of
developmental disabilities to
professionals throughout the United
States and abroad.
Dated: March 22, 2006.
William H. Gimson,
Chief Operating Officer, Centers for Disease
Control and Prevention (CDC).
[FR Doc. 06–3123 Filed 3–30–06; 8:45 am]
BILLING CODE 4160–18–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifier: CMS 250–254 and
CMS 10171]
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Centers for Medicare &
Medicaid Services.
In compliance with the requirement
of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the
Centers for Medicare & Medicaid
Services (CMS), Department of Health
AGENCY:
PO 00000
Frm 00032
Fmt 4703
Sfmt 4703
16311
and Human Services, is publishing the
following summary of proposed
collections for public comment.
Interested persons are invited to send
comments regarding this burden
estimate or any other aspect of this
collection of information, including any
of the following subjects: (1) The
necessity and utility of the proposed
information collection for the proper
performance of the Agency’s function;
(2) the accuracy of the estimated
burden; (3) ways to enhance the quality,
utility, and clarity of the information to
be collected; and (4) the use of
automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
1. Type of Information Collection
Request: Extension of a currently
approved collection; Title of
Information Collection: Medicare
Secondary Payer Information Collection
and Supporting Regulations in 42 CFR
411.25, 489.2, and 489.20; Form
Number: CMS 250–254 (OMB#: 0938–
0214); Use: Medicare Secondary Payer
Information (MSP) is essentially the
same concept known in the private
insurance industry as coordination of
benefits, and refers to those situations
where Medicare does not have primary
responsibility for paying the medical
expenses of a Medicare beneficiary.
Medicare Fiscal Intermediaries, Carriers,
and now Part D plans, need information
about primary payers in order to
perform various tasks to detect and
process MSP cases and make recoveries.
MSP information is collected at various
times and from numerous parties during
a beneficiary’s membership in the
Medicare Program. Collecting MSP
information in a timely manner means
that claims are processed correctly the
first time, decreasing the costs
associated with adjusting claims and
recovering mistaken payments.;
Frequency: Reporting—On Occasion;
Affected Public: Individuals or
Households, Business or other for-profit,
Not-for-profit institutions; Number of
Respondents: 134,553,682; Total
Annual Responses: 134,553,682; Total
Annual Hours: 1,611,303.
2. Type of Information Collection
Request: Extension of a currently
approved collection; Title of
Information Collection: Coordination of
Benefits between Part D Plans and Other
Prescription Coverage Providers; Form
Number: CMS 10171 (OMB#: 0938–
0978); Use: Section 1860D–23 and
1860D–24 of the Social Security Act
requires the Secretary to establish
requirements for prescription drug plans
to ensure effective coordination between
Part D plans, State pharmaceutical
E:\FR\FM\31MRN1.SGM
31MRN1
]]>Agencies
[Federal Register Volume 71, Number 62 (Friday, March 31, 2006)]
[Notices]
[Pages 16310-16311]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-3123]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Statement of Organization, Functions, and Delegations of
Authority
Part C (Centers for Disease Control and Prevention) of the
Statement of Organization, Functions, and Delegations of Authority of
the Department of Health and Human Services (45 FR 67772-76, dated
October 14, 1980, and corrected at 45 FR 69296, October 20, 1980, as
amended most recently at 71 FR 6777, dated February 9, 2006) is amended
to reflect the reorganization of the Division of Birth Defects and
Developmental Disabilities, within the National Center on Birth Defects
and Developmental Disabilities.
Section C-B, Organization and Functions, is hereby amended as
follows:
After the mission statement for the Division of Birth Defects and
Developmental Disabilities (CUBB), insert the following:
Office of the Director (CUBB1). (1) Manages, directs, and
coordinates the research agenda and activities of the division; (2)
provides leadership and guidance on strategic planning, policy, program
and project priority planning and setting, program management, and
operations; (3) establishes division goals, objectives, and priorities;
(4) monitors progress in implementation of projects and achievement of
objectives; (5) plans, allocates, and monitors resources; (6) provides
management, administrative, and support services, and coordinates with
appropriate NCBDDD offices on program and administrative matters; (7)
provides liaison with other CDC organizations, other governmental
agencies, international organizations, and other outside groups; (8)
provides support for internal scientific advisory groups; (9) provides
scientific leadership and guidance to the division to assure highest
scientific quality and professional standards; and (10) provides
coordinative support for CDC's efforts to reduce adverse consequences
from birth defects, developmental disabilities, and pediatric genetic
conditions.
Birth Defects Branch (CUBBB). (1) Designs and conducts
epidemiologic and genetic research to identify causes and risk factors
of birth defects; (2) conducts evaluates interventions to improve
infant and child health by preventing or reducing the adverse
consequences of birth defects; (3) designs and conducts surveillance of
selected birth defects to identify rates, trends, and patterns of
occurrence, and to evaluate the effectiveness of prevention programs;
(4) disseminates findings of studies to the scientific and public
health communities, and to the general public; (5) provides technical
assistance to state and local agencies on surveillance of birth
defects, epidemiologic research, prevention program design and
evaluation, and prevention effectiveness research; (6) funds and
coordinates grant and cooperative agreement programs and other
extramural activities to improve the knowledge base for the prevention
of birth defects through surveillance, epidemiologic research, and
applies research of preventive interventions; (7) coordinates
activities with other CDC functional units, HHS, other federal
agencies,and appropriate private organizations regarding research and
prevention programs for birth defects; (8) works with international
organizations in developing strategies for the prevention of birth
defects; and (9) disseminates findings of research through direct
contact with health authorities, publication and distribution of
special reports, publication in scientific and technical journals,
conference presentations, and other appropriate means.
Prevention Research Branch (CUBBC). (1) Modifies the impact of
prenatal exposures leading to adverse physical and developmental
impairments in infants, children, and adults including integrating
successful prevention programs into social and medical
[[Page 16311]]
environments, and evaluating innovative, effective, and strategic
health promotion programs; (2) develops, implements, evaluates, and
disseminates education and communication interventions that lead to the
prevention of birth defects and developmental disabilities; (3) designs
and conducts surveillance of preventable birth defects and
developmental disabilities to identify rates, trends, and patterns of
occurrence, and to evaluate the effectiveness of prevention programs;
(4) disseminates findings of epidemiologic studies to the scientific
and public health communities, and to the general public; (5) conducts
prevention effectiveness research to evaluate interventions strategies
for the prevention of birth defects and developmental disabilities; (6)
identifies and monitors major preconception, prenatal and perinatal
risks, and protective factors for fetal alcohol spectrum disorders
(FASD) and other prenatal alcohol-attributable conditions; (7) provides
technical assistance to state and local agencies on surveillance,
epidemiologic research, prevention program design and evaluation, and
prevention effectiveness research; (8) funds and coordinates grant and
cooperative agreement programs and other extramural activities to
improve the knowledge base for the prevention of birth defects and
developmental disabilities through surveillance, epidemiologic
research, and applies research of preventive interventions; (9)
coordinates activities with other CDC functional units, HHS, other
federal agencies and appropriate private organizations regarding
research and prevention programs for birth defects and developmental
disabilities; (10) works with international organizations in developing
strategies for the prevention of birth defects and developmental
disabilities; and (11) disseminates finding of research through direct
contact with health authorities, publication and distribution of
special reports, publication in scientific and technical journals,
conference presentations, and other appropriate means.
Developmental Disabilities Branch (CUBBD). (1) Designs and conducts
surveillance of developmental disabilities to identify rates, trends,
and patterns of occurrence, and to evaluate the effectiveness of
prevention programs; (2) conducts epidemiologic studies of
developmental disabilities to identify causes and risk factors for
these conditions; (3) disseminates findings of epidemiologic studies to
the scientific and public health communities and to the general public;
(4) conducts prevention effectiveness research to evaluate
interventions strategies for the prevention of developmental
disabilities; (5) conducts epidemiologic studies to identify and
describe specific conditions and long-term outcomes of developmental
disabilities; (6) provides technical assistance to state and local
agencies on surveillance of developmental disabilities, epidemiologic
research, prevention program design and evaluation, and prevention
effectiveness research; (7) funds and coordinates grant and cooperative
agreement programs and other extramural activities to improve the
knowledge base for the prevention of developmental disabilities through
surveillance, epidemiologic research, and applies research of
preventive interventions; (8) coordinates activities with other CDC
functional units, HHS, other Federal agencies and appropriate private
organizations regarding research and prevention programs for
developmental disabilities; (9) collaborates with international
organizations in developing strategies for the prevention of
developmental disabilities; (10) disseminates findings of research
through direct contact with health authorities, publication and
distribution of special reports, publication in scientific and
technical journals, conference presentations, and other appropriate
means; and (11) provides training in the epidemiology of developmental
disabilities to professionals throughout the United States and abroad.
Dated: March 22, 2006.
William H. Gimson,
Chief Operating Officer, Centers for Disease Control and Prevention
(CDC).
[FR Doc. 06-3123 Filed 3-30-06; 8:45 am]
BILLING CODE 4160-18-M
